Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 39 - Medicinal preparations containing antigens or antibodies
Patents for A61K 39 - Medicinal preparations containing antigens or antibodies (182,248)
11/2003
11/19/2003EP1361794A2 Pro-apoptotic bacterial vaccines to enhance cellular immune responses
11/19/2003EP1047446B1 Vaccine composition for herpes simplex virus and methods of using
11/19/2003EP1011723B1 88kda tumorigenic growth factor and antagonists
11/19/2003EP0921855B1 Isolation of immunoglobulins
11/19/2003EP0767673B1 Methods for reduced renal uptake of antibody fragments
11/19/2003EP0760859B1 Shuttle vectors for the introduction of dna into mycobacteria and utilization of such bacteria as vaccines
11/19/2003EP0733066B1 Pretargeting methods and compounds
11/19/2003EP0720485B1 Method of activating soluble carbohydrate using novel cyanylating reagents for the production of immunogenic constructs
11/19/2003CN1457259A Method for preventing and curing diseases of immune system and remedy for carrying out said method
11/19/2003CN1457258A Methods of treating viral diseases with IL-18 and IL-18 compositions
11/19/2003CN1456664A Reorganized human glycogen phosphorylase isoenzyme BB and preparation thereof by methanal yeast and use thereof
11/19/2003CN1456355A Forest cerebritis purifying vaccinum
11/19/2003CN1456354A Vaccin for preventing marine culturing animals from vibriosis and its preapration and use
11/19/2003CN1456353A Senile dementia vaccinum and preparing method thereof
11/19/2003CN1128218C Rotavirus causing adult's diarrhea and its culture process
11/19/2003CN1128157C Conjugate of lidamycin with active fragment of monoclonal antibody
11/19/2003CN1127985C Fowl marek's disease vaccine synergist and its preparation
11/19/2003CN1127983C Inmunization adjusting anti-inflamation agent
11/19/2003CN1127982C Antitumor cell-protein preparation
11/18/2003US6649747 Composition and method for diagnosing auto-immune hepatitis
11/18/2003US6649744 Rnase P polypeptides, polynucleotides, and methods using their mechanisms of action
11/18/2003US6649743 Monoclonal antibody against estrogen stimulated leucine aminopeptidase
11/18/2003US6649741 Tumor antigen-derived gene (TADG) of given sequence; detecting binding of antibody to the protein; useful in diagnosis, treatment and prevention; breast and ovarian
11/18/2003US6649589 Blocking tumor necrosis factor activity with soluble cytokine receptor, monoclonal antibody or tetracycline derivative
11/18/2003US6649421 Antigen binding protein; use in diagnosis and treatment of cardiac infarction, stroke, arterial occlusion disease and kidney failure due to endothelial dysfunction
11/18/2003US6649410 Method for the development of an HIV vaccine
11/18/2003US6649409 Method for producing a nucleotide sequence construct with optimized codons for an HIV genetic vaccine based on a primary, early HIV isolate and synthetic envelope BX08 constructs
11/18/2003US6649391 Isolated polynucleotide encoding a polypeptide of given sequence; dephosphorylates MAP(mitogen activated protein)-kinase; used for modulating cell proliferation, differentiation and survival
11/18/2003US6649388 Polypeptides derived from JNK3
11/18/2003US6649374 Recombinant Chlamydia trachomatis PGP3 antigen
11/18/2003US6649372 Which expresses heterologous nucleotide sequences; introducing expression vectors, nucleotprotein, and polymerase into a cell; allowing complex to form; culturing; use in vaccines
11/18/2003US6649370 Isolated polynucleotide which induces a immune response when administered to a mammal; expression vectors; vaccines
11/18/2003US6649342 Methods of diagnosing breast cancer, compositions, and methods of screening for breast cancer modulators
11/18/2003US6649172 5-(p-carboxybenzyloxy)-2-oxybenzaldehyde derivatives; vaccine adjuvants
11/18/2003US6649171 Diagnostic, prophylactic and therapeutic uses, i.e. vaccines; antibiotic resistant bacteria responsible for much of the otitis media in young children
11/18/2003US6649170 Adjuvant combinations for immunization composition and vaccines
11/18/2003US6649169 Cold-adapted equine influenza viruses
11/18/2003US6649167 Papillomavirus truncated L1 protein and fusion protein constructs
11/18/2003US6649166 Peptides and proteins for desensitizing subjects allergic to bee venom and compositions containing same
11/18/2003US6649164 (RANK); RANK is a member of the TNF superfamily; used to regulate an immune response
11/18/2003US6649157 Treating a Ras-mediated cell proliferative disorder in a mammal, by administering a modified adenovirus, modified HSV, modified vaccinia virus or modified parapoxvirus orf virus resulting in lysis of the proliferating cells.
11/18/2003US6649143 Non-invasive localization of a light-emitting conjugate in a mammal
11/18/2003CA2143845C Self-assembling recombinant papillomavirus capsid proteins
11/17/2003CA2429483A1 Immunointeractive molecules
11/13/2003WO2003093793A2 Binary or polynary targeting and uses thereof
11/13/2003WO2003093510A1 Compositions and methods relating to colon specific genes and proteins
11/13/2003WO2003093486A1 In situ generation of viral vectors
11/13/2003WO2003093485A2 Optimization of transgene expression in mammalian cells
11/13/2003WO2003093478A1 Immunoconjugates for the treatment of tumours
11/13/2003WO2003093463A1 Improved viral purification methods
11/13/2003WO2003093455A2 Adenovirus vectors for immunotherapy
11/13/2003WO2003093443A2 Alcam and alcam modulators
11/13/2003WO2003093422A2 Novel tissue factor targeted antibodies as anticoagulants
11/13/2003WO2003093416A2 Protective antigens for the control of ixodes species infestations
11/13/2003WO2003093320A2 Antibodies specific for human cd22 and their therapeuatic and digagnostic uses
11/13/2003WO2003093318A1 Novel antibody binding tcr and tirc7 and its use in therapy and diagnosis
11/13/2003WO2003093315A2 Specific antibody fragments for the human carcinoembryonic antigen (cea)
11/13/2003WO2003093313A2 Antagonists of factor viii interaction with low-density lipoprotein receptor-related protein
11/13/2003WO2003093307A2 Mycobacterial antigens and uses thereof
11/13/2003WO2003093306A2 Nucleic acids and proteins from streptococcus groups a & b
11/13/2003WO2003093298A2 Immunogenic peptides
11/13/2003WO2003092815A1 Method and agents for the prevention, inhibition, and therapy of cancers
11/13/2003WO2003092739A1 Non-viral gene delivery system
11/13/2003WO2003092732A1 Ph-sensitive polymer
11/13/2003WO2003092728A1 Encapsulated cells to elicit immune response
11/13/2003WO2003092717A1 Cancer immunotherapy
11/13/2003WO2003092716A2 Therapeutic use of pacap, maxadilan, pacap receptor agonist and/or adcyap1r1 in the treatment of cns disorders
11/13/2003WO2003092714A2 Peptide variants of ige constrained by beta-lactam bond
11/13/2003WO2003092708A1 Antitumor agents with the use of hsv
11/13/2003WO2003092657A1 Microparticles bearing cells and active substances
11/13/2003WO2003092624A2 Use of heat shock proteins to enhance efficacy of antibody therapeutics
11/13/2003WO2003092623A2 Calicheamicin derivative-carrier conjugates
11/13/2003WO2003092619A2 Prevention and treatment of type 2 diabetes
11/13/2003WO2003092610A2 Methods of using cytokine antagonists to treat hiv infection and aids
11/13/2003WO2003092602A2 Novel tissue factor targeted thrombomodulin fusion proteins as anticoagulants
11/13/2003WO2003092600A2 Site specific listeria integration vectors and methods for using the same
11/13/2003WO2003092592A2 Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3'-utr of dengue types 1,2,3, and 4, or antigenic chimeric dengue viruses 1,2,3, and 4
11/13/2003WO2003092582A2 Chimeric ebola virus envelopes and uses therefor
11/13/2003WO2003092479A2 Treatments and methods for the treatment, diagnosis and prophylaxis
11/13/2003WO2003080654A3 Helicobacter flagellar, motility polypeptides
11/13/2003WO2003080111A3 Chemotherapeutic agents as anti-cancer vaccine adjuvants and therapeutic methods thereof
11/13/2003WO2003075826A3 Process for manufacturing pharmaceutical composition comprises of mycobacterium w in the treatment of asthma(obstructive lung disease)
11/13/2003WO2003068804A3 Novel insect cell line
11/13/2003WO2003066680A3 Antigens for immunocontraception
11/13/2003WO2003060143A3 Efficient protein expression system
11/13/2003WO2003051392A3 Streptococcus pneumoniae vaccine
11/13/2003WO2003042244A3 Immunogenic mimetics of multimer proteins with promiscuous t cell epitope inserts
11/13/2003WO2003033654A3 Direct targeting binding proteins
11/13/2003WO2003033653A3 Affinity enhancement agents
11/13/2003WO2003031942A8 Reagents and methods useful for detecting diseases of the breast
11/13/2003WO2003029436A3 Ul16 binding protein 4
11/13/2003WO2003027316A3 Methods of using 33751, a human potassium channel family member
11/13/2003WO2003022360A3 Thermotherapy via targeted delivery of nanoscale magnetic particles
11/13/2003WO2003009778A3 Methods and devices for delivery of therapeutic capable agents with variable release profile
11/13/2003WO2003000918A3 Nucleic acids, polypeptides, single nucleotide polymorphisms and methods of use thereof
11/13/2003WO2003000227A3 A method for preparation of vesicles loaded with biological material and different uses thereof
11/13/2003WO2003000117A3 Detection and treatment of prostate cancer
11/13/2003WO2002098443A3 Stabilised mrna with an increased g/c content and optimised codon for use in gene therapy
11/13/2003WO2002079252A8 Isolated human transporter protein, nucleic acid molecules encoding human transporter protein, and uses thereof
11/13/2003WO2002079243A3 Gonococcal proteins and nucleic acids
1 ... 1196 1197 1198 1199 1200 1201 1202 1203 1204 1205 1206 1207 1208 1209 1210 1211 1212 1213 1214 1215 1216 ... 1823